GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Novavax Inc. (NVAX) on Thursday reported a loss of $81 million in its fourth quarter.
On a per-share basis, the Gaithersburg, Maryland-based company said it had a loss of 51 cents.
The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 75 cents per share.
The vaccine maker posted revenue of $88.3 million in the period, which also beat Street forecasts. Five analysts surveyed by Zacks expected $86.4 million.
For the year, the company reported a loss of $187.5 million, or $1.23 per share. Revenue was reported as $682.2 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVAX at https://www.zacks.com/ap/NVAX
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。